Drug intelligence / Profile preview

3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a small molecule belonging to the class of phenyl-substituted triazolopyrimidines. It features a benzoic acid moiety attached to a triazolopyrimidine core with amino and hydroxy functional groups. The structure suggests it is an experimental or research chemical rather than an approved pharmaceutical agent. There are no known clinical indications or approvals for this compound as of now. Its mechanism of action and biological targets have not been characterized in publicly available drug databases[2][4]. It has been referenced in chemical libraries such as ZINC15 Pharmaceuticals and listed in DrugBank (DB01906), but without detailed pharmacological data.

Other names
3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid3-(5-amino-7-hydroxy-2H-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid3-{5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl}benzoic acid

Beyond the preview

Go deeper on 3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call